Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by steadfaston Apr 07, 2015 9:20am

185 Views

Post# 23603364

RE:RE:RE:RE:RE:RE:Another point to raise at AGM

Thank you Donkeyfeathers. I now understand. Yes, it makes sense the hosts
for the IRAP Grant could be animals. One needs a medical background to get
a full grasp of SVA. I visited the gov site in Feb and recall that Dr Shapiro's next
date for results was June 15, 2015. I will try to find the site where I found this
today. Consequently, I am not expecting any news til then.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta